Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
1,294
-34
-3% -$11.6K 0.41% 65
2026
Q1
$467K Sell
1,328
-11
-0.8% -$3.92K 0.47% 57
2025
Q4
$438K Sell
1,339
-51
-4% -$16.2K 0.45% 64
2025
Q3
$367K Buy
+1,390
New +$403K 0.54% 54

Other funds holding AMGN

Invested Advisors's AMGN Position: Q2 2026 in Review

Invested Advisors reduced its Amgen (AMGN) stake by 2.6% in Q2 2026, selling an estimated $11.6K and leaving 1,294 shares worth $469K. The position accounts for 0.41% of the portfolio, ranked #65.

Invested Advisors first reported a position in AMGN in Q3 2025 and has held it in 4 quarters since. 1,827 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Invested Advisors held 1,294 shares of Amgen worth $469K as of Q2 2026.
  • Invested Advisors sold 34 Amgen shares in Q2 2026, an estimated $11.6K.
  • Amgen made up 0.41% of Invested Advisors's portfolio in Q2 2026, its #65 holding.
  • Invested Advisors first reported a position in Amgen in Q3 2025 and has held it in 4 quarters since.
  • 1,827 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Invested Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.